Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Morris

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Nature|July 2, 2025
Publisher Correction: Metabolic adaptations direct cell fate during tissue regenerationAlmudena Chaves-Perez, Scott E Millman, Sudha Janaki-Raman, et al.
Elife|June 1, 2023
MLL3 regulates the <i>CDKN2A</i> tumor suppressor locus in liver cancerChangyu Zhu, Yadira M Soto-Feliciano, John P Morris, et al.
Cell|September 3, 2021
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas CancerMarcus Ruscetti, John P Morris, Riccardo Mezzadra, et al.
Cell|April 3, 2020
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas CancerMarcus Ruscetti, John P Morris, Riccardo Mezzadra, et al.
Nature|February 4, 2021
A gene-environment-induced epigenetic program initiates tumorigenesisDirena Alonso-Curbelo, Yu-Jui Ho, Cassandra Burdziak, et al.
Nature Cancer|May 4, 2023
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillanceLoretah Chibaya, Katherine C Murphy, Kelly D DeMarco, et al.
Blood|January 10, 2025
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemiaScott E Millman, Almudena Chaves-Perez, Sudha Janaki-Raman, et al.
Immunity|May 27, 2025
Enhancer-driven gene regulatory networks reveal transcription factors governing T cell adaptation and differentiation in the tumor microenvironmentWilliam D Green, Amber Gomez, Alec L Plotkin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2022
A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targetsXiang Li, Chun-Hao Huang, Francisco J Sánchez-Rivera, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Oncogenic and tumor-suppressive forces converge on a progenitor-orchestrated niche to shape early tumorigenesisJosé Reyes, Isabella Del Priore, Andrea C Chaikovsky, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Nature|July 2, 2025
Publisher Correction: Metabolic adaptations direct cell fate during tissue regenerationAlmudena Chaves-Perez, Scott E Millman, Sudha Janaki-Raman, et al.
Elife|June 1, 2023
MLL3 regulates the <i>CDKN2A</i> tumor suppressor locus in liver cancerChangyu Zhu, Yadira M Soto-Feliciano, John P Morris, et al.
Cell|September 3, 2021
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas CancerMarcus Ruscetti, John P Morris, Riccardo Mezzadra, et al.
Cell|April 3, 2020
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas CancerMarcus Ruscetti, John P Morris, Riccardo Mezzadra, et al.
Nature|February 4, 2021
A gene-environment-induced epigenetic program initiates tumorigenesisDirena Alonso-Curbelo, Yu-Jui Ho, Cassandra Burdziak, et al.
Nature Cancer|May 4, 2023
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillanceLoretah Chibaya, Katherine C Murphy, Kelly D DeMarco, et al.
Blood|January 10, 2025
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemiaScott E Millman, Almudena Chaves-Perez, Sudha Janaki-Raman, et al.
Immunity|May 27, 2025
Enhancer-driven gene regulatory networks reveal transcription factors governing T cell adaptation and differentiation in the tumor microenvironmentWilliam D Green, Amber Gomez, Alec L Plotkin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2022
A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targetsXiang Li, Chun-Hao Huang, Francisco J Sánchez-Rivera, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Oncogenic and tumor-suppressive forces converge on a progenitor-orchestrated niche to shape early tumorigenesisJosé Reyes, Isabella Del Priore, Andrea C Chaikovsky, et al.
Pageof 5